Ask AI
ProCE Banner Activity

LACRIS: Real-world LA CAB + RPV in People With HIV-1 Subtype A6

Conference Coverage
Slideset

Interim findings from the real-world, retrospective matched-case study in centers across Poland, Germany, and the Czech Republic examine the impact of subtype A6 vs subtype B on the efficacy of LA CAB + RPV.

Released: November 17, 2026

Share

Provided by

Provided by Clinical Care Options, LLC dba Decera Clinical Education

ProCE Banner

Supporters

This activity is supported by educational grants from Gilead Sciences, Inc. and ViiV Healthcare.

Gilead Sciences, Inc.

ViiV Healthcare

Target Audience

This activity is intended for physicians, pharmacists, registered nurses, and other healthcare professionals who care for people living with or at risk of HIV infection.

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Appropriately apply and counsel patients regarding the clinical role(s) of new and investigational ART regimens and strategies

  • Devise HIV management strategies based on the results of recent clinical studies of established antiretroviral agents

  • Integrate the latest scientific findings to develop and optimize effective HIV prevention interventions